tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MDCX Stock Latest News

Medicus Pharma Showcases Strong Phase 2 SkinJect Data Ahead of Fireside Chat
Company AnnouncementsMedicus Pharma Showcases Strong Phase 2 SkinJect Data Ahead of Fireside Chat
5d ago
MDCX
Medicus Pharma to discuss Skinject Phase 2 reults in fireside chat
PremiumThe Fly
Medicus Pharma to discuss Skinject Phase 2 reults in fireside chat
5d ago
MDCX
Medicus Pharma Highlights Strong Phase 2 SkinJect Data Ahead of Business Update Call
PremiumCompany Announcements
Medicus Pharma Highlights Strong Phase 2 SkinJect Data Ahead of Business Update Call
7d ago
MDCX
Medicus Pharma announces SkinJect Phase 2 KOL update
PremiumThe Fly
Medicus Pharma announces SkinJect Phase 2 KOL update
7d ago
MDCX
Medicus Pharma to Spotlight AI-Driven Drug Development at Longwood Miami CEO Forum
PremiumCompany Announcements
Medicus Pharma to Spotlight AI-Driven Drug Development at Longwood Miami CEO Forum
13d ago
MDCX
Medicus Pharma Highlights Strong Phase 2 SkinJect Results in Basal Cell Carcinoma
PremiumCompany AnnouncementsMedicus Pharma Highlights Strong Phase 2 SkinJect Results in Basal Cell Carcinoma
14d ago
MDCX
Medicus Pharma provides interpretation of Phase 2 SkinJect dataset
Premium
The Fly
Medicus Pharma provides interpretation of Phase 2 SkinJect dataset
14d ago
MDCX
Medicus Pharma Raises Equity Financing, Reduces Yorkville Debenture
Premium
Company Announcements
Medicus Pharma Raises Equity Financing, Reduces Yorkville Debenture
17d ago
8K
MDCX
Medicus Pharma Posts Strong Phase 2 Data for Microneedle Basal Cell Carcinoma Therapy
PremiumCompany Announcements
Medicus Pharma Posts Strong Phase 2 Data for Microneedle Basal Cell Carcinoma Therapy
18d ago
MDCX
Medicus Pharma announces results from Phase 2 study of D-MNA
PremiumThe Fly
Medicus Pharma announces results from Phase 2 study of D-MNA
18d ago
MDCX
Medicus Pharma announces results from Phase 2 study of D-MNA
PremiumThe Fly
Medicus Pharma announces results from Phase 2 study of D-MNA
18d ago
MDCX
Medicus Pharma Showcases SkinJect and Teverelix Strategy at Roth Conference
PremiumCompany Announcements
Medicus Pharma Showcases SkinJect and Teverelix Strategy at Roth Conference
20d ago
MDCX
Medicus Pharma Wins FDA Go-Ahead for Phase 2b Teverelix Trial in High-Risk Prostate Cancer
PremiumCompany AnnouncementsMedicus Pharma Wins FDA Go-Ahead for Phase 2b Teverelix Trial in High-Risk Prostate Cancer
1M ago
MDCX
Medicus Pharma Wins FDA Go-Ahead for Phase 2b Teverelix Trial in High-Risk Prostate Cancer
Premium
Company Announcements
Medicus Pharma Wins FDA Go-Ahead for Phase 2b Teverelix Trial in High-Risk Prostate Cancer
1M ago
MDCX
Medicus signs six-part media series with New to the Street
Premium
The Fly
Medicus signs six-part media series with New to the Street
1M ago
MDCX
Medicus receives FDA ‘study may proceed’ clearance for Teverelix Phase 2b study
PremiumThe Fly
Medicus receives FDA ‘study may proceed’ clearance for Teverelix Phase 2b study
1M ago
MDCX
Medicus Pharma Lowers Teverelix Royalty Burden in Amended LifeArc License
PremiumCompany Announcements
Medicus Pharma Lowers Teverelix Royalty Burden in Amended LifeArc License
2M ago
MDCX
Medicus announces amendment to LifeArc license improving Teverelix profile
PremiumThe Fly
Medicus announces amendment to LifeArc license improving Teverelix profile
2M ago
MDCX
Medicus Pharma Highlights Positive Teverelix Phase 1 Data and Near-Term SkinJect Milestones
PremiumCompany Announcements
Medicus Pharma Highlights Positive Teverelix Phase 1 Data and Near-Term SkinJect Milestones
2M ago
MDCX
Medicus Pharma announces clinical data on Teverelix
PremiumThe FlyMedicus Pharma announces clinical data on Teverelix
2M ago
MDCX
Medicus Pharma Ramps Up Partnering Push as Phase 2 SkinJect Data Nears
Premium
Company Announcements
Medicus Pharma Ramps Up Partnering Push as Phase 2 SkinJect Data Nears
3M ago
MDCX
Medicus Pharma Launches At-the-Market Equity Offering Program
Premium
Company Announcements
Medicus Pharma Launches At-the-Market Equity Offering Program
3M ago
8K
MDCX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >